[go: up one dir, main page]

TW350847B - New process for preparing norbenzomorphan, an intermediate in the preparation of pharmaceutically useful benzomorphan derivatives, particularly (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphan - Google Patents

New process for preparing norbenzomorphan, an intermediate in the preparation of pharmaceutically useful benzomorphan derivatives, particularly (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphan

Info

Publication number
TW350847B
TW350847B TW085108979A TW85108979A TW350847B TW 350847 B TW350847 B TW 350847B TW 085108979 A TW085108979 A TW 085108979A TW 85108979 A TW85108979 A TW 85108979A TW 350847 B TW350847 B TW 350847B
Authority
TW
Taiwan
Prior art keywords
benzomorphan
hydroxy
compound
norbenzomorphan
preparing
Prior art date
Application number
TW085108979A
Other languages
English (en)
Inventor
Matthias Grauert
Herbert Merz
Hanfried Baltes
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Application granted granted Critical
Publication of TW350847B publication Critical patent/TW350847B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
TW085108979A 1995-08-03 1996-07-23 New process for preparing norbenzomorphan, an intermediate in the preparation of pharmaceutically useful benzomorphan derivatives, particularly (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphan TW350847B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19528472A DE19528472A1 (de) 1995-08-03 1995-08-03 Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan

Publications (1)

Publication Number Publication Date
TW350847B true TW350847B (en) 1999-01-21

Family

ID=7768562

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085108979A TW350847B (en) 1995-08-03 1996-07-23 New process for preparing norbenzomorphan, an intermediate in the preparation of pharmaceutically useful benzomorphan derivatives, particularly (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphan

Country Status (30)

Country Link
US (3) US5945535A (zh)
EP (1) EP0842153B1 (zh)
JP (1) JP3887756B2 (zh)
KR (1) KR100399669B1 (zh)
CN (1) CN1125053C (zh)
AR (1) AR003167A1 (zh)
AT (1) ATE201672T1 (zh)
AU (1) AU703700B2 (zh)
BR (1) BR9609959A (zh)
CA (1) CA2228511C (zh)
CO (1) CO4750808A1 (zh)
CZ (1) CZ292589B6 (zh)
DE (2) DE19528472A1 (zh)
DK (1) DK0842153T3 (zh)
ES (1) ES2157004T3 (zh)
GR (1) GR3036417T3 (zh)
HU (1) HU222038B1 (zh)
IL (1) IL118992A (zh)
MX (1) MX9800357A (zh)
NO (1) NO308247B1 (zh)
NZ (1) NZ316463A (zh)
PL (1) PL185218B1 (zh)
PT (1) PT842153E (zh)
RU (1) RU2167868C2 (zh)
SI (1) SI0842153T1 (zh)
TR (1) TR199800164T1 (zh)
TW (1) TW350847B (zh)
UA (1) UA64699C2 (zh)
WO (1) WO1997006146A1 (zh)
ZA (1) ZA966588B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan
DE19740110A1 (de) * 1997-09-12 1999-03-18 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19822822A1 (de) * 1998-05-20 1999-11-25 Boehringer Ingelheim Pharma Verbessertes Verfahren zur Herstellung von pharmazeutisch wertvollen Norbenzomorphanderivaten
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
US6495694B2 (en) 2000-06-16 2002-12-17 Boehringer Ingelheim Pharma Kg Efficient separation of enantiomers of piperidone derivatives by precipitation of the desired eantiomer during in situ racemization of the unwanted enantiomer
DE10029851A1 (de) * 2000-06-16 2001-12-20 Boehringer Ingelheim Pharma Enantiomerentrennung von Piperidon-Derivaten unter gleichzeitiger in situ Racemisierung des unerwünschten Enantiomers
DE10130020A1 (de) * 2001-06-25 2003-12-04 Gruenenthal Gmbh Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate
CN1171892C (zh) * 2001-06-25 2004-10-20 李晶 具有抗炎镇痛活性的噻吩并噻嗪化合物及其制备方法和用途
KR20040039732A (ko) * 2002-11-04 2004-05-12 주식회사 동진쎄미켐 캠포릴이 결합된 펜던트 기를 가지는 화학적으로 증폭된고분자와 그 제조방법, 및 이를 포함하는 레지스트 조성물
CN104829662B (zh) * 2015-03-30 2017-11-07 石药集团欧意药业有限公司 一种阿奇霉素有关物质的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34235B1 (en) * 1969-06-04 1975-03-19 Acf Chemiefarma Nv 6,7-benzomorphans and their preparation
US4012392A (en) * 1969-06-04 1977-03-15 Acf Chemiefarma N.V. 2-Benzyl-4-piperidones useful as intermediates in the production of 6,7-benzomorphan derivatives
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
NL7907800A (nl) * 1979-10-23 1981-04-27 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan, farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen en de farmaceutische preparaten.
DE4121821A1 (de) * 1991-07-02 1993-01-14 Boehringer Ingelheim Kg Neue benzomorphane und ihre verwendung als arzneimittel
US5607941A (en) * 1992-06-26 1997-03-04 Boehringer Ingelheim Kg Useful for treating neurodegenerative diseases
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan

Also Published As

Publication number Publication date
DE19528472A1 (de) 1997-02-06
CA2228511C (en) 2007-11-06
IL118992A (en) 2000-06-01
NO308247B1 (no) 2000-08-21
TR199800164T1 (xx) 1998-04-21
NO980449D0 (no) 1998-02-02
US6140502A (en) 2000-10-31
CA2228511A1 (en) 1997-02-20
JPH11511135A (ja) 1999-09-28
DE59607007D1 (de) 2001-07-05
EP0842153B1 (de) 2001-05-30
DK0842153T3 (da) 2001-08-06
EP0842153A1 (de) 1998-05-20
CN1125053C (zh) 2003-10-22
HUP9900360A2 (hu) 1999-06-28
AU6870296A (en) 1997-03-05
ES2157004T3 (es) 2001-08-01
PL324859A1 (en) 1998-06-22
US5945535A (en) 1999-08-31
US6054604A (en) 2000-04-25
ZA966588B (en) 1997-02-03
KR100399669B1 (ko) 2004-03-24
WO1997006146A1 (de) 1997-02-20
PT842153E (pt) 2001-09-28
PL185218B1 (pl) 2003-04-30
GR3036417T3 (en) 2001-11-30
JP3887756B2 (ja) 2007-02-28
NO980449L (no) 1998-02-02
ATE201672T1 (de) 2001-06-15
CN1190959A (zh) 1998-08-19
AR003167A1 (es) 1998-07-08
UA64699C2 (en) 2004-03-15
HK1010537A1 (zh) 1999-06-25
HUP9900360A3 (en) 1999-11-29
HK1015362A1 (zh) 1999-10-15
RU2167868C2 (ru) 2001-05-27
HU222038B1 (hu) 2003-03-28
IL118992A0 (en) 1996-11-14
CZ292589B6 (cs) 2003-10-15
KR19990036091A (ko) 1999-05-25
NZ316463A (en) 1999-07-29
SI0842153T1 (en) 2001-10-31
AU703700B2 (en) 1999-04-01
CZ31598A3 (cs) 1998-07-15
MX9800357A (es) 1998-07-31
BR9609959A (pt) 1999-02-02
CO4750808A1 (es) 1999-03-31

Similar Documents

Publication Publication Date Title
TW350847B (en) New process for preparing norbenzomorphan, an intermediate in the preparation of pharmaceutically useful benzomorphan derivatives, particularly (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphan
IE43450B1 (en) New 6,7-benzomorphans, methods for their preparation and new intermediates
CA1049511A (en) 2-tetrahydrofurfuryl-6,7-benzomorphanes, their acid addition salts, their use as pharmaceuticals and processes for their production
UA27254C2 (uk) Похідні дипептидів та спосіб їх отримання
ES2149734T3 (es) Metodo para la preparacion de citalopram.
ATE18863T1 (de) Verfahren zur herstellung freifliessender ethyl- cellulose-mikrokapseln.
KR890011851A (ko) 이소 키놀린 유도체, 그 제조방법 및 사용방법
Grundon et al. Stereochemical aspects of the biological oxidation of aryl isoprenoids. The asymmetric synthesis and absolute configuration of meranzin and of meranzin hydrate
AU560980B2 (en) New vitro alphatic compounds
MY104424A (en) Stereospecific process for the preparation of furo [3,4-c]pyridine enantiomers and compounds thus obtained
WO1995034194A3 (en) Process for manufacturing clavulanic acid salt
EP1092720A3 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
IE780151L (en) Benzisoquinolines
IE32936B1 (en) Benzomorphan derivatives
Assante et al. Dothistromin and 2-epidothistromin from Cercospora smilacis
Huang et al. Isobraunicene, wolficene, and isowolficene. New cyclic 1'-3 fused isoprenoids from Botryococcus braunii
Hanaoka et al. Transformation of protoberberines into spirobenzylisoquinolines. Stereoselective conversion of coptisine into (±)-ochrobirine
Fraga et al. Carotdiol esters from Ferula linkii
CA2380853A1 (en) Process for the preparation of acylated 1,3-dicarbonyl compounds
ES2107391A1 (es) Procedimiento para la preparacion de carotenoides y pigmentos que los contienen.
DE3262166D1 (en) A new p-chlorophenoxyacetic acid derivative, its method of preparation and pharmaceutical composition
US3215738A (en) N-(substituted-phenethyl)-1-hydroxy-1-cycloalkyl-ethylamines
JPS5772981A (en) 1,8-naphthyridine derivative and its salt
Dobler et al. Microbial hydroxylation of some synthetic Aristotelia alkaloids
JPS57183757A (en) 5-oxopyrrolidine derivative, antiulcer comprising it as active ingredient, and its preparation